title: EGFR R521K predicts cetuximab response in KRAS wild-type patients.
authors: Faculty of Pharmacy & Pharmaceutical Sciences, 3142F Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, AB, T6G 2E1, Canada. smarsh@pharmacy.ualberta.ca
authors: Sharon
authors: S
authors: Marsh